Investigation of the effects of omega-3 on immune system in patients with thyroid cancer under the treatment with radioiodine
Phase 4
- Conditions
- cancer.cancer
- Registration Number
- IRCT20220104053622N1
- Lead Sponsor
- ational Institute for Medical Research Development
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Involving with differentiated thyroid cancer
Adult patients
Total or near-total thyroidectomy
Planned for radioiodine ablation with 150 mCi or 100 mCi
Exclusion Criteria
Patients who will be received radioiodine at doses higher than 150 mCi
Patients who were previously received radioiodine
Patients who had taken omega-3 or other supplements before the study
Patients who had undergone a second thyroid surgery
Patients who have other cancers
Patients who have concurrent chronic inflammatory disease
Patients who have autoimmune disease or other cancers
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cytokine change. Timepoint: 30 days before RAI, Just before RAI, 7 & 30 days after RAI. Method of measurement: Cytometric bead-based assay.
- Secondary Outcome Measures
Name Time Method